...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins.
【24h】

Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins.

机译:依那普利逆转自发性高血压大鼠心脏肥大及收缩蛋白的表达。

获取原文
           

摘要

Several experimental models involving the development of cardiac hypertrophy in adult rats are characterized by the reexpression of the fetal isoform of myosin heavy chain (V3). To determine whether a similar adult-to-fetal shift in the expression of the thin-filament proteins occurs during cardiac hypertrophy, we have examined the expression of the isoforms of myosin, tropomyosin, and troponin T in the left ventricle of young spontaneously hypertensive rats (SHR) with and without treatment using enalapril, an angiotensin converting enzyme inhibitor. Phosphorylation of tropomyosin, which is predominant in the fetal state, was also analyzed. Twelve-week-old SHR were treated with enalapril for 2, 5, 8, and 9 weeks followed by withdrawal of treatment for 9 weeks. Control SHR, without drug treatment, were weight- and age-matched. After 9 weeks of enalapril treatment, mean arterial blood pressure was reduced (from 166 +/- 11 to 89 +/- 5 mm Hg), and left ventricular weight/body weight ratio was regressed (from 2.53 +/- 0.14 to 1.96 +/- 0.05 g/kg) to normotensive levels. During the 9-week treatment period, the percent V3 decreased in SHR substantially from 35 +/- 3% to 13 +/- 1%. There was a significant correlation between the left ventricular hypertrophy and the percent V3 myosin expression in the SHR during regression (r = 0.697, p less than 0.001). However, only the adult isoforms of tropomyosin and troponin T were detected in the SHR with or without enalapril treatment, and the level of tropomyosin phosphorylation remained constant irrespective of the degree of left ventricular hypertrophy.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:涉及成年大鼠心脏肥大发展的几种实验模型的特征是肌球蛋白重链(V3)的胎儿亚型的重新表达。为了确定在心肌肥大过程中细丝蛋白表达是否发生了类似的从成年人到胎儿的转变,我们检查了年轻自发性高血压大鼠左心室肌球蛋白,原肌球蛋白和肌钙蛋白T亚型的表达(SHR)使用或不使用血管紧张素转化酶抑制剂依那普利进行治疗。还分析了以胎儿状态为主的原肌球蛋白的磷酸化。用依那普利治疗12周的SHR,2、5、8和9周,然后停药9周。未经药物治疗的对照SHR体重和年龄相匹配。依那普利治疗9周后,平均动脉血压从166 +/- 11降低到89 +/- 5 mm Hg,左心室重量/体重比从2.53 +/- 0.14降低到1.96 + /-0.05 g / kg)至血压正常水平。在9周的治疗期间,SHR中的V3百分比从35 +/- 3%下降到13 +/- 1%。回归期间,SHR中左心室肥大与V3肌球蛋白表达百分比之间存在显着相关性(r = 0.697,p小于0.001)。然而,无论是否接受依那普利治疗,SHR均仅检测到原肌原肌球蛋白和肌钙蛋白T的同工型,无论原发性左心室肥大程度如何,原肌球蛋白的磷酸化水平均保持恒定。(摘要摘录于250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号